Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +47.8% | +71.5% | 2 / 3 | -0.3% | +1.37 pp | +1.91 pp | +10.9% | 0.03 | 6.11 | 416 | −0,3% | 25,5 | +44,9% | 6.11 | 7.63 | −20,0% |
| Pts | 8 | 12 | 8 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 12.800 (close price on 2026-10-19)EPS (TTM): 2.096
Financial charts
1.Revenue & growth
VND bn416Q2/26
1.Revenue & growth
VND bn416Q2/26
2.Profit & growth
VND bn23,8Q2/26
3.Profit mix (Penman)
VND bn91,7Q2/26
4.Margins & cost structure
%7.1%Q2/26
5.Returns & cash cycle
% · days15.2%Q2/26
6.Earnings quality & cash
VND bn78,7Q2/26
7.Asset structure
VND bn951Q2/26
8.Funding & debt health
VND bn · times951Q2/26
9.Revenue backlog
VND bn1,25Q2/26
10.Valuation
times · %6,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %749Q2/26
Adjusted EPS growth, latest quarter
47.8%
Average adjusted EPS growth, 3 quarters
71.5%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26